Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29,821 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lerociclib plus fulvestrant in patients with HR+/HER2- locally advanced or metastatic breast cancer who have progressed on prior endocrine therapy: LEONARDA-1 a phase III randomized trial.
Xu B, Zhang Q, Luo Y, Tong Z, Sun T, Shan C, Liu X, Yao Y, Zhao B, Wang S, Zeng X, Hu C, Yan X, Wang X, Jia H, Chen Z, Qiu F, Wu X, Zhang D, Li T. Xu B, et al. Among authors: luo y. Nat Commun. 2025 Jan 16;16(1):716. doi: 10.1038/s41467-025-56096-2. Nat Commun. 2025. PMID: 39820749 Clinical Trial.
Concordance and pathogenicity of copy number variants detected by non-invasive prenatal screening in 38,611 pregnant women without fetal structural abnormalities.
Liu Y, Wang J, Wang L, Chen L, Xie D, Wang L, Liu S, Liu J, Bai T, Jing X, Deng C, Xia T, Cheng J, Xing L, Wei X, Luo Y, Zhou Q, Liu L, Zhu Q, Liu H. Liu Y, et al. Among authors: luo y. Chin Med J (Engl). 2025 Jan 17. doi: 10.1097/CM9.0000000000003449. Online ahead of print. Chin Med J (Engl). 2025. PMID: 39820083 No abstract available.
29,821 results
You have reached the last available page of results. Please see the User Guide for more information.